Project CBD
JULY 2, 2018
Many of our patients have called in asking about cannabinoid hyperemesis syndrome ( CHS ), as this syndrome has been reported in the media numerous times over the past few months. CHS was first reported in the medical literature in 2004. This is a very rare syndrome that occurs in long-term heavy users of THC -rich cannabis.
The Cannigma
OCTOBER 19, 2022
Medical marijuana is not technically legal, but cannabinoid-based medications are. The same year, the government reclassified cannabinoids to make them available for medical use. Still, officially the market is only 18 years old, as the country joined the EU in 2004, and thus fell into compliance with EU hemp regulations.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
United Patients Group
FEBRUARY 22, 2023
The symptoms can be so severe that some patients require hospitalization for dehydration. If you are looking to receive professional advice from cannabis-friendly medical professionals , look no further than our expertise here at United Patients Group. appeared first on United Patients Group. CHS may affect an estimated 0.2%
FloridaMarijuana.net
JUNE 22, 2018
Patients who suffer from this condition also face other symptoms that are painful, inconvenient -to say the least, -and lower their quality of life. An article published on the marijuanadoctor.com website discusses the best strains of marijuana for patients with IBS.
Otherside Farms
JANUARY 23, 2019
Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain.
Greencamp
FEBRUARY 17, 2019
The stress response in IBS patients causes abnormalities in the functioning of the sympathetic nervous system (one of the divisions of the autonomic or “subconscious” nervous system) and to the HPA axis. We produce endocannabinoids—internal cannabinoid-like compounds, that bind to these cellular endocannabinoid receptors.
The Cannigma
OCTOBER 9, 2021
Studies demonstrate that cannabis and its cannabinoid constituents have an implication on human urinary function. The common understanding is that every individual has a separate and different reaction to cannabinoid-based therapy, the same is true with how it might influence individual urinary symptoms.
Expert insights. Personalized for you.
223 
Let's personalize your content